FNY Investment Advisers’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27K | Buy |
+500
| New | +$27K | 0.01% | 511 |
|
|
2025
Q1 | – | Sell |
-1,000
| Closed | -$38K | – | 878 |
|
|
2024
Q4 | $38K | Buy |
+1,000
| New | +$38K | 0.02% | 362 |
|
|
2018
Q4 | – | Sell |
-3,000
| Closed | -$30K | – | 866 |
|
|
2018
Q3 | $30K | Buy |
3,000
+500
| +20% | +$5K | 0.01% | 393 |
|
|
2018
Q2 | $16K | Buy |
+2,500
| New | +$16K | 0.01% | 355 |
|